Navigation Links
Decrease in sense of smell seen in lupus patients
Date:4/30/2009

The sense of smell is a complex process of the central nervous system that involves specific areas of the brain. In fact, olfactory dysfunction is seen in various central nervous system disorders that involve immune-mediated mechanisms, such as Parkinson's disease, schizophrenia, Alzheimer's disease and multiple sclerosis. Systemic lupus erythematosus (SLE) is an autoimmune disease that sometimes involves the central nervous system in a condition known as neuropsychiatric SLE (NPSLE). Research in mice has shown that NPSLE-like symptoms and olfactory impairment might be induced by autoimmune mechanisms that target specific areas of the brain, but this has not been explored. A new study assessed olfactory function in SLE patients and found that there is a decrease in the sense of smell compared with healthy controls. The study was published in the May issue of Arthritis & Rheumatism (http://www3.interscience.wiley.com/journal/76509746/home).

Led by Yehuda Shoenfeld of Chaim Sheba Medical Center in Tel-Hashomer, Israel, the study involved 50 SLE patients and 50 age and sex-matched controls. Researchers evaluated three levels of olfactory function: threshold (identifying a stick with an odor from among sticks that didn't have an odor); discrimination (differentiating between two smells); and identification of a smell from among four options. The three scores were combined to form a total TDI score.

The results showed significant olfactory deficits in the SLE patients compared with the controls. SLE patients showed a decrease in olfactory function in both the threshold and discrimination tests. In addition, the study found that patients with more active disease and past NPSLE manifestations had significantly lower TDI scores. Past research in mice has shown that injection of antibodies linked to NPSLE manifestations induced olfactory deficit and that these antibodies can bind and penetrate cells in limbic areas of the brain, which are associated with the sense of smell. In addition, magnetic resonance imaging has recently shown limbic system involvement in SLE patients. "Although the exact mechanism of olfactory impairment has yet to be elucidated, the possibility of an immune-mediated mechanism is intriguing," the authors note.

The incidence of olfactory dysfunction in the general population is a matter of debate. About one percent of the population is believed to have a loss of the sense of smell; in the study, loss of smell was seen only in SLE patients, 10 percent of whom suffered from this condition. The importance of the sense of smell is easy to appreciate, since the inability to detect odors in daily life, for example in food that has spoiled or leaks in a gas line, could seriously compromise a person's health.

The authors point out that olfaction is unfamiliar territory for rheumatologists and immunologists, but results from this and other studies demonstrate that an autoimmune mechanism may play a role in olfactory impairment. They conclude that "smell decrement has been found to be an early and predictive sign in several CNS diseases, and therefore, might be a useful and easy tool for the physician in early diagnosis of CNS involvement in autoimmune diseases."


'/>"/>

Contact: Sean Wagner
medicalnews@bos.blackwellpublishing.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
2. Excluding the lateral view in chest radiograph screenings decreases radiation exposure by 67 percent
3. Treating HIV earlier to decrease the risk of death
4. Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer
5. Some radiation therapy treatments can decrease fertility
6. Universal vaccination associated with decreased Canadian cases of most deadly strain of meningitis
7. Device aims to decrease wait period for patients needing immunotherapy
8. Seniors in Medicares doughnut hole decrease use of meds
9. Mammography utilization in the United States decreases: A state-level look
10. Controversial medication may decrease spasms for infants with epilepsy
11. Risk takers, drug abusers driven by decreased ability to process dopamine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: